Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.65
(-0.44%)
CNY 13.65
(-0.44%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.56 Billion CNY | 13.98% |
| 2022 | 1.39 Billion CNY | 7.48% |
| 2021 | 1.29 Billion CNY | 15.79% |
| 2020 | 1.11 Billion CNY | -6.49% |
| 2019 | 1.19 Billion CNY | 3.72% |
| 2018 | 1.15 Billion CNY | -6.07% |
| 2017 | 1.22 Billion CNY | 10.02% |
| 2016 | 1.11 Billion CNY | 12.07% |
| 2015 | 994.91 Million CNY | -5.36% |
| 2014 | 1.05 Billion CNY | -0.53% |
| 2013 | 1.05 Billion CNY | 14.41% |
| 2012 | 923.74 Million CNY | 11.19% |
| 2011 | 830.8 Million CNY | 16.79% |
| 2010 | 711.37 Million CNY | -16.87% |
| 2009 | 855.76 Million CNY | 16.78% |
| 2008 | 732.79 Million CNY | 12.9% |
| 2007 | 649.05 Million CNY | 15.95% |
| 2006 | 559.77 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 440.14 Million CNY | 22.85% |
| 2024 Q3 | 380.16 Million CNY | -13.63% |
| 2024 Q1 | 358.27 Million CNY | -6.9% |
| 2023 FY | 1.58 Billion CNY | 13.98% |
| 2023 Q4 | 384.81 Million CNY | 18.18% |
| 2023 Q1 | 535.97 Million CNY | 53.58% |
| 2023 Q2 | 338.95 Million CNY | -36.76% |
| 2023 Q3 | 325.6 Million CNY | -3.94% |
| 2022 Q4 | 348.98 Million CNY | 7.75% |
| 2022 Q3 | 323.88 Million CNY | -1.97% |
| 2022 Q2 | 330.37 Million CNY | -14.79% |
| 2022 Q1 | 387.7 Million CNY | -4.39% |
| 2022 FY | 1.39 Billion CNY | 7.48% |
| 2021 Q3 | 278.48 Million CNY | -9.71% |
| 2021 Q1 | 301.69 Million CNY | -7.59% |
| 2021 Q2 | 308.44 Million CNY | 2.24% |
| 2021 FY | 1.29 Billion CNY | 15.79% |
| 2021 Q4 | 405.49 Million CNY | 45.61% |
| 2020 Q3 | 248.25 Million CNY | -23.62% |
| 2020 Q1 | 217.83 Million CNY | -41.39% |
| 2020 FY | 1.11 Billion CNY | -6.49% |
| 2020 Q4 | 326.48 Million CNY | 31.51% |
| 2020 Q2 | 325.05 Million CNY | 49.22% |
| 2019 Q1 | 277.29 Million CNY | -17.28% |
| 2019 FY | 1.19 Billion CNY | 3.72% |
| 2019 Q4 | 371.69 Million CNY | 54.19% |
| 2019 Q3 | 241.05 Million CNY | -21.0% |
| 2019 Q2 | 305.12 Million CNY | 10.04% |
| 2018 FY | 1.15 Billion CNY | -6.07% |
| 2018 Q4 | 335.2 Million CNY | 33.76% |
| 2018 Q3 | 250.6 Million CNY | -20.14% |
| 2018 Q2 | 313.81 Million CNY | 24.22% |
| 2018 Q1 | 252.62 Million CNY | -41.05% |
| 2017 Q3 | 263.7 Million CNY | -9.43% |
| 2017 Q1 | 243.36 Million CNY | -37.22% |
| 2017 FY | 1.22 Billion CNY | 10.02% |
| 2017 Q4 | 428.52 Million CNY | 62.5% |
| 2017 Q2 | 291.16 Million CNY | 19.64% |
| 2016 Q3 | 247.49 Million CNY | -5.76% |
| 2016 FY | 1.11 Billion CNY | 12.07% |
| 2016 Q4 | 387.63 Million CNY | 56.62% |
| 2016 Q1 | 213.33 Million CNY | -38.47% |
| 2016 Q2 | 262.64 Million CNY | 23.11% |
| 2015 Q2 | 288.53 Million CNY | 80.2% |
| 2015 Q4 | 346.74 Million CNY | 73.79% |
| 2015 FY | 994.91 Million CNY | -5.36% |
| 2015 Q1 | 160.12 Million CNY | -51.49% |
| 2015 Q3 | 199.51 Million CNY | -30.85% |
| 2014 Q2 | 264.55 Million CNY | 23.79% |
| 2014 FY | 1.05 Billion CNY | -0.53% |
| 2014 Q4 | 330.06 Million CNY | 35.88% |
| 2014 Q3 | 242.9 Million CNY | -8.18% |
| 2014 Q1 | 213.7 Million CNY | -32.75% |
| 2013 Q4 | 317.76 Million CNY | 21.16% |
| 2013 FY | 1.05 Billion CNY | 14.41% |
| 2013 Q1 | 258.14 Million CNY | -12.52% |
| 2013 Q2 | 218.64 Million CNY | -15.3% |
| 2013 Q3 | 262.26 Million CNY | 19.95% |
| 2012 Q2 | 204.75 Million CNY | 7.99% |
| 2012 FY | 923.74 Million CNY | 11.19% |
| 2012 Q4 | 295.09 Million CNY | 25.96% |
| 2012 Q1 | 189.61 Million CNY | -25.31% |
| 2012 Q3 | 234.27 Million CNY | 14.42% |
| 2011 Q3 | 216.44 Million CNY | 8.16% |
| 2011 Q1 | 160.37 Million CNY | -26.58% |
| 2011 Q2 | 200.1 Million CNY | 24.78% |
| 2011 FY | 830.8 Million CNY | 16.79% |
| 2011 Q4 | 253.88 Million CNY | 17.3% |
| 2010 Q4 | 218.43 Million CNY | 31.01% |
| 2010 Q3 | 166.72 Million CNY | -1.5% |
| 2010 FY | 711.37 Million CNY | -16.87% |
| 2010 Q1 | 156.95 Million CNY | -47.7% |
| 2010 Q2 | 169.26 Million CNY | 7.85% |
| 2009 Q4 | 300.11 Million CNY | 57.66% |
| 2009 Q3 | 190.36 Million CNY | -21.9% |
| 2009 Q2 | 243.75 Million CNY | 100.58% |
| 2009 FY | 855.76 Million CNY | 16.78% |
| 2009 Q1 | 121.52 Million CNY | -53.31% |
| 2008 Q3 | 151.17 Million CNY | 0.0% |
| 2008 Q4 | 260.26 Million CNY | 72.17% |
| 2008 FY | 732.79 Million CNY | 12.9% |
| 2007 FY | 649.05 Million CNY | 15.95% |
| 2006 FY | 559.77 Million CNY | 0.0% |